1. Home
  2. ARMP vs ISNR Comparison

ARMP vs ISNR Comparison

Compare ARMP & ISNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Armata Pharmaceuticals Inc.

ARMP

Armata Pharmaceuticals Inc.

SELL

Current Price

$3.02

Market Cap

199.7M

Sector

Health Care

ML Signal

SELL

ISNR

Snow Rothschild Acquisition Corp. Class A Ordinary Shares

N/A

Current Price

$9.81

Market Cap

221.9M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
ARMP
ISNR
Founded
N/A
2026
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Blank Checks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
199.7M
221.9M
IPO Year
1996
2026

Fundamental Metrics

Financial Performance
Metric
ARMP
ISNR
Price
$3.02
$9.81
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
★ $17.50
N/A
AVG Volume (30 Days)
★ 75.7K
51.2K
Earning Date
11-12-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.40
$9.80
52 Week High
$14.98
$9.95

Technical Indicators

Market Signals
Indicator
ARMP
ISNR
Relative Strength Index (RSI) 46.59 49.29
Support Level $2.77 $9.80
Resistance Level $3.96 $9.92
Average True Range (ATR) 0.44 0.01
MACD -0.02 0.00
Stochastic Oscillator 43.35 37.97

Price Performance

Historical Comparison
ARMP
ISNR

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.

About ISNR Snow Rothschild Acquisition Corp. Class A Ordinary Shares

Snow Rothschild Acquisition Corp is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.

Share on Social Networks: